Infusion Laboratory: Protocol 2 (Lisuride) - 3
Phase 1
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 2
- Registration Number
- NCT00000338
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Alternate-Day Buprenorphine Administration. Phase VI - 7
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000225
- Locations
- ๐บ๐ธ
Treatment Research Center, Burlington, Vermont, United States
Alternate-Day Buprenorphine Administration. Phase IV - 5
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000223
- Locations
- ๐บ๐ธ
Treatment Research Center, Burlington, Vermont, United States
Alternate-Day Buprenorphine Administration. Phase I - 3
Phase 1
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000221
- Locations
- ๐บ๐ธ
Treatment Research Center, Burlington, Vermont, United States
High Dose Nimodipine Treatment Adjunct - 1
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000332
- Locations
- ๐บ๐ธ
Washington DC VA, Washington, District of Columbia, United States
Selegiline in Outpatient Treatment for Cocaine Dependence - 1
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000336
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Psychostimulant Abuse - Novel Treatment Approaches - 1
Phase 1
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000325
- Locations
- ๐บ๐ธ
McLean Hospital, Dept. of Psychiatry, Belmont, Massachusetts, United States
Therapeutic Potential of Kappa-Opioids Against Cocaine - 1
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 10
- Registration Number
- NCT00000323
- Locations
- ๐บ๐ธ
Johns Hopkins University (BPRU) Bayview Campus, Baltimore, Maryland, United States
Cocaine Abuse and ADHD - 10
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 16
- Registration Number
- NCT00000275
- Locations
- ๐บ๐ธ
New York State Psychiatric Institute, New York, New York, United States
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Phase 2
Completed
- Conditions
- Substance-Related DisordersOpioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000352
- Locations
- ๐บ๐ธ
University of Pennsylvania, Philadelphia, Pennsylvania, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath